Search clinical trials for: Protein Hydrolysates

Total 22211 results

University of Ulster
University of Limerick; Bio-Marine Ingredients Ireland

Not yet recruiting

Fish Protein Supplementation and Sarcopenia Outcomes in Carehomes (SARCO_CARE)

Sarcopenia
Umeå University
Lund University; Arla Foods

Recruiting

Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula (GRANDIOSA)

Infant Formula

Sweden
University of Ulster
University of Limerick; Bio-Marine Ingredients Ireland

Not yet recruiting

Fish Protein Supplementation and Sarcopenia Outcomes in the Community (SARCO_COMM)

Sarcopenia

United Kingdom
Claudia Luévano-Contreras

Completed

Black Bean (Phaseolus Vulgaris L.) Protein Hydrolysates Reduce Acute Postprandial Glucose Levels

PreDiabetes

Mexico
Helse Møre og Romsdal HF
University of Bergen; Haukeland University Hospital

Completed

Marin Protein Hydrolysate and Metabolic Syndrome (MPH_MetS)

Metabolic Syndrome

Norway
University of Seville

Completed

Safety and Efficacy of a Drink Containing Lupine Protein Hydrolysates on the Immune, Oxidative and Metabolic Status

Healthy Volunteers

Spain
Helse Møre og Romsdal HF
Haukeland University Hospital

Completed

Marine Protein Hydrolysate as Dietary Supplement in Elderly Part II (MPH-DR)

Healthy Volunteers

Norway
University of Limerick

Completed

Whey Protein Support to Metabolic and Performance Adaptations in Response HIIT

Exercise | Muscle, Skeletal | High-Intensity Interval Training

Ireland
Universidade Federal do Rio de Janeiro

Completed

Vascular Function, Fish Protein Hydrolysates and Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Brazil
Helse Møre og Romsdal HF
Haukeland University Hospital

Completed

Marine Protein Hydrolysate as Dietary Supplement in Elderly Part I (MPH-BS)

Healthy Volunteers

Norway
Molde University College

Completed

Effect Study of Marine Protein Hydrolysates to Prevent Loss of Muscle Mass and Physical Function in Frail Elderly

Sarcopenia
Helse Møre og Romsdal HF
University of Bergen; Haukeland University Hospital

Completed

Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome (MPH_IBS)

Irritable Bowel Syndrome

Norway
Atlantia Food Clinical Trials

Terminated

Effect of Protein Hydrolysates on HbA1c Levels in Pre-diabetics

PreDiabetes

Ireland
United Pharmaceuticals

Completed

A Double-blind Randomized Controlled Trial of a Thickened Amino-acid-based Formula in Children Allergic to Cow's Milk and to Protein Hydrolysates

Cow Milk Allergy

France
Texas A&M University

Completed

Hydrolyzed Casein and Whey Protein Supplementation and the Addition of Leucine to Induce Protein Anabolism in Malnourished COPD Patients

Chronic Obstructive Pulmonary Disease

United States
Changzhi People's Hospital Affiliated to Changzhi...

Recruiting

A Real-world Study of Camrelizumab Alone or in Combination With Apatinib/Chemotherapy for Advanced Gastric Cancer

Gastric Cancer | PD-1 Immunotherapy | RWS

China
Guohui Xu

Recruiting

TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma

Unresectable Hepatocellular Carcinoma | Apatinib | Camrelizumab | Transarterial Chemoembolization

China
Boehringer Ingelheim

Not yet recruiting

Real-life-persistence to Antifibrotic Treatments (REPEAT)

Idiopathic Pulmonary Fibrosis

France
Region Skane
Swedish Lung Cancer Study Group

Recruiting

EGFR-mutated Lung Cancer in Randomized Investigator-Initiated Study (ERIS)

Non-Small Cell Lung Cancer

Sweden
Assistance Publique Hopitaux De Marseille

Not yet recruiting

Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and Ependymoma (MEPENDAX)

Ependymoma | Medulloblastoma
University Health Network, Toronto
Myeloma Canada; The Leukemia and Lymphoma Society of Canada

Not yet recruiting

Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma

Lymphoma, B-Cell | Multiple Myeloma | B Cell Lymphoma | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Multiple Myeloma Progression | Multiple Myeloma Stage III | Aggressive Lymphoma
Brigham and Women's Hospital
Medical University of South Carolina; M.D. Anderson Cancer Center; Massachusetts... and other collaborators

Recruiting

Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy

Multiple Myeloma | Acute Kidney Injury | Light Chain Nephropathy

United States
Washington University School of Medicine
Pfizer; National Comprehensive Cancer Network; Rapid Novor

Not yet recruiting

Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance Using Peripheral Blood Clonotypic Mass Spectrometry

Multiple Myeloma

United States
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting

A Clinical Study of SHR-9539 in Patients With Multiple Myeloma

Multiple Myeloma

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Recruiting

Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.

Acute Myeloid Leukemia

China
Jin Ying

Recruiting

A Study of Adebrelimab Combined With Apatinib Mesylate and Chemotherapy for Neoadjuvant Therapy and Biomarker Analysis in Limited-stage Small Cell Lung Cancer

Small Cell Lung Cancer Limited Stage

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases (LungBrain001)

Adenocarcinoma of Lung Metastatic to Brain
Chengdu Zenitar Biomedical Technology Co., Ltd

Not yet recruiting

Puesta Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Relapsed or Refractory Multiple Myeloma (RRMM)

China
Sun Yat-sen University

Not yet recruiting

HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study

Hepatocellular Carcinoma
University Hospital, Grenoble

Not yet recruiting

Validation of an Alzheimer's Disease Marker by Fecal Assay of Amyloid Peptides and Tau Proteins (FecAlz)

Alzheimer Disease
West China Hospital

Recruiting

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

Locally Advanced Thyroid Gland Carcinoma

China
University Medical Center Groningen

Not yet recruiting

Bleeding in Multiple Myeloma (BiMM)

Multiple Myeloma
Christian Schmidt, MD
Johannes Gutenberg University Mainz

Recruiting

CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma (CARMAN)

Mantle Cell Lymphoma

Germany
Yunpeng Liu
Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Small Cell Lung Cancer

Small Cell Lung Cancer

China
University Health Network, Toronto
Ontario Shores Centre for Mental Health Sciences

Recruiting

i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial (Ket-CBT)

Suicide | Major Depressive Disorder | Treatment Resistant Depression

Canada
Pfizer

Not yet recruiting

Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

Relapsed and Refractory Multiple Myeloma (RRMM)
Charite University, Berlin, Germany

Recruiting

Influence of Protein Intake on Muscle Mass and Health-related Quality of Life During and After Radiotherapy (pROtein)

Malnutrition; Cachexia

Germany
Hunan Province Tumor Hospital

Not yet recruiting

The Recurrence Gene Profiles of Adjuvant Osimertinib Therapy in Resected Non-Small-Cell Lung Cancer (RAISE)

Non-small Cell Lung Cancer
Henan Cancer Hospital

Recruiting

Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib

Hepatocellular Carcinoma

China
Assiut University

Recruiting

The Effect of Active Nutritional Support On Quality Of Life In Patients With Head And Neck Cancer Receiving Radiotherapy

Head and Neck Neoplasms

Egypt
Universitaire Ziekenhuizen KU Leuven
Janssen Pharmaceutica

Not yet recruiting

Study on the Clinical Efficacy of Teclistamab (TECTONIC)

Hematologic Diseases | Multiple Myeloma

Belgium
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Not yet recruiting

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Refractory Differentiated Thyroid Gland Carcinoma
Bristol-Myers Squibb

Not yet recruiting

A Study Evaluating Deucravacitinib Concentrations in the Breast Milk and Plasma of Healthy Lactating Female Participants

Healthy Volunteers
Tang-Du Hospital
Jiangsu Hengrui Pharmaceutical Co., Ltd.

Recruiting

Adebrelimab + Apatinib in SCLC Maintenance Therapy

SCLC

China
RenJi Hospital

Not yet recruiting

Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves

Anticoagulation
M.D. Anderson Cancer Center

Not yet recruiting

A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute Leukemias

Refractory Acute Leukemia | Relapsed Acute Leukemia

United States
National Institute of Allergy and Infectious Diseases...

Not yet recruiting

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients (CLAD)

Lung Transplant

United States, Canada
Chang Gung Memorial Hospital

Recruiting

Study To Evaluate The Efficacy Of Tofacitinib In Patients With SJS/TEN

Stevens-Johnson Syndrome | Toxic Epidermal Necrolysis

Taiwan
AC Camargo Cancer Center

Recruiting

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors (EVENET)

Progression | Neuroendocrine Tumors | Neuroendocrine Tumor of the Lung | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1 | Neuroendocrine Tumor of Pancreas | Neuroendocrine Tumor Carcinoid

Brazil
Tianjin Medical University Cancer Institute and...

Not yet recruiting

Zanubrutinib and G-CHOP in Untreated Intermediate-high Risk Follicular Lymphoma

FL

Search clinical trials for: Protein Hydrolysates

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations